17
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Age-Related Macular Degeneration and Its Risk Factors in North Africans Living in Algeria and Italy

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose: To determine the risk factors for age-related macular degeneration (AMD) in Algerians, and compare these data with those on North Africans living in Italy. Methods: All patients over 55 years of age consulting one of the 23 involved Algerian ophthalmologists were invited to participate, and 1,183 patients were included. Data collection was standardized based on the Simplified Théa Risk Assessment Scale (STARS) questionnaire. A similar study was conducted in North Africans living in Italy (n = 1,011). Patients with only soft drusen and/or pigmentary abnormalities were classified as early AMD, and patients with geographic atrophy and/or neovascular AMD were classified as late AMD. Results: In the final multivariate model, risk for early and/or late AMD was significantly increased with older age, family history of AMD, Black ethnicity, atherosclerosis, beer consumption, high fruit consumption, cataract surgery, myopia, and hyperopia. High consumption of green vegetables was associated with lower risk for both early and late AMD. In comparison with North Africans from Italy, Algerians generally had a healthier profile (younger, less obesity, smoking, and cardiovascular diseases, and higher consumption of fruits and vegetables) and a lower risk for AMD. Conclusion: This study documents risk factors for AMD in North-African populations for the first time.

          Related collections

          Author and article information

          Journal
          ORE
          Ophthalmic Res
          10.1159/issn.0030-3747
          Ophthalmic Research
          S. Karger AG
          0030-3747
          1423-0259
          2016
          September 2016
          14 July 2016
          : 56
          : 3
          : 145-154
          Affiliations
          aOphthalmology, Private Practice, Blida, bOphthalmology Department, Khemis Miliana Hospital, Ain Delfa, cOphthalmology Department, Béni Slimane Hospital, Medea, dOphthalmology, Private Practice, Ain El Bey, eOphthalmology, Private Practice, El Khroub, fOphthalmology, Private Practice, Hussein Dey, gOphthalmology, Private Practice, El Biar, and hOphthalmology Department, Béni Messous University Hospital, Algiers, Algeria; iUniversité de Bordeaux, ISPED, and jINSERM, U1219 - Bordeaux Population Health Research Center, Bordeaux, kBiostatem, Castries, and lLaboratoires Théa, Clermont-Ferrand, France; mDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy
          Author notes
          *Cécile Delcourt, Inserm U1219, ISPED, Université de Bordeaux, 146 rue Léo Saignat, FR-33076 Bordeaux Cedex (France), E-Mail cecile.delcourt@isped.fr
          Author information
          https://orcid.org/0000-0002-2099-0481
          Article
          446844 Ophthalmic Res 2016;56:145-154
          10.1159/000446844
          27410056
          ec83eb02-fcc8-496e-8cee-0622c352c91d
          © 2016 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 10 May 2016
          : 12 May 2016
          Page count
          Tables: 6, References: 38, Pages: 10
          Categories
          Original Paper

          Vision sciences,Ophthalmology & Optometry,Pathology
          Macular degeneration,Risk factors,North Africa,Epidemiology

          Comments

          Comment on this article